Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Mankind Pharma Secures Interim Injunction Against Biodiscovery Over Fendikind, Zenkind, Kind Trademarks

Power supply issue at Mankind Pharma Sikkim facility, operations disrupted

Ruchika Sharma6 Oct 2023 2:30 PM IST

New Delhi: Mankind Pharma has informed that operations at its manufacturing facility at Daring Block, Berimok, Namchi Zilla, South Sikkim have been...

Sun Pharma Told to Revise Delafloxacin Phase III Trial Protocol

USFDA accepts Sun Pharma NDA for alopecia areata drug Deuruxolitinib

Ruchika Sharma6 Oct 2023 1:52 PM IST

Mumbai: Sun Pharmaceutical Industries Ltd has announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application...

Fire at Amritsar pharma unit, 4 killed

Ruchika Sharma6 Oct 2023 12:30 PM IST

Four people were killed after a major fire broke out inside a pharmaceutical factory on the outskirts of Amritsar city on Thursday night, police said....

Lupin Nagpur facility completes USFDA inspection

Lupin Tolvaptan tablets wins USFDA okay

Ruchika Sharma6 Oct 2023 11:36 AM IST

This product will be manufactured at Lupin's Nagpur facility in India.

UP STF Set to Name Pharma Firms in Multi-Crore Codeine Syrup Scam

More Indian pharma cos in spotlight over contaminated syrup samples

Ruchika Sharma5 Oct 2023 3:30 PM IST

New Delhi: Samples of syrups manufactured by two pharmaceutical companies based in Gujarat and Tamil Nadu have been found to have contaminants...

Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilities

Sanofi-Teva Pharma to co-develop, co-commercialize inflammatory bowel disease treatment

Ruchika Sharma5 Oct 2023 2:30 PM IST

Paris: Sanofi and Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. have announced a collaboration to co-develop and...

Roche Diagnostics ropes in Rishubh Gupta as new MD for India, neighbouring markets

Ruchika Sharma5 Oct 2023 1:30 PM IST

New Delhi: Roche Diagnostics India has said it has appointed Rishubh Gupta as its new Managing Director for India and neighbouring markets.Gupta will...

Alembic Pharma secures USFDA approval for Travoprost Ophthalmic Solution

Flash floods in Teesta River: Alembic Pharma Sikkim plant manufacturing operations disrupted

Ruchika Sharma5 Oct 2023 12:30 PM IST

New Delhi: Alembic Pharmaceuticals has said flash floods in the Teesta River has led to disruption in operations at its Sikkim-based manufacturing...

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

Strides Pharma bags USFDA nod for Efavirenz, Emtricitabine, Tenofovir Disproxil Fumurate tablets for HIV

Ruchika Sharma5 Oct 2023 11:36 AM IST

Bangalore: Strides Pharma Science Limited has announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has...

Novartis concludes Sandoz spin-off

Ruchika Sharma5 Oct 2023 10:30 AM IST

Basel: Novartis has completed the Spin-off of Sandoz, its Generics and Biosimilars business, through a dividend-in-kind distribution to holders of...

Sanofis Tetraxim Vaccine Gets CDSCO Panel Nod for Expanded Indication

Sanofi, Janssen ink pact to develop vaccine for extraintestinal pathogenic E. coli

Ruchika Sharma4 Oct 2023 5:30 PM IST

Sanofi will pay USD 175M upfront to Janssen, followed by development and commercial milestones.

Takeda to voluntary withdraw lung cancer therapy Exkivity

Ruchika Sharma4 Oct 2023 4:30 PM IST

Osaka: Takeda has announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok